Group invulnerability as COVID-19 system unsafe, nations must make opportune mediations: CSIR Kumar Jeetendra | June 1, 2020 Putting money on creating group insusceptibility to battle coronavirus is “too enormous a hazard” for any country and just opportune intercessions can alleviate the spread of COVID-19, Director General of the Council of Scientific and Industrial Research (CSIR) Shekhar Mande said. Group insusceptibility is accomplished when most of populace gets resistant to an irresistible malady, …
Focuses for COVID-19 immunization recognized by researchers Kumar Jeetendra | June 9, 2020 Researchers have identified regions of the SARS-CoV-2 infection that causes COVID-19 to focus with an antibody, by saddling apparatuses utilized for the improvement of malignant growth immunotherapies. The scientists at Children’s’ Hospital of Philadelphia (CHOP) in the US utilized a similar methodology used to inspire a resistant reaction against malignant growth cells to invigorate a …
In a first in Kerala, Apheresis strategy used to manage plasma to COVID-19 patient Kumar Jeetendra | June 13, 2020 Upgradation of framework at a Government Medical College Hospital close here proved to be useful to oversee plasma to a coronavirus tolerant from a benefactor restored of COVID-19, utilizing apheresis strategy without precedent for Kerala. A clinical hardware that does the apheresis system was introduced at the GMCH at close by Thrissur a month ago …
Moderna competes with US researchers over COVID-19 antibody preliminaries Kumar Jeetendra | July 7, 2020 As america hastens the search to get a coronavirus vaccine, tensions have escalated between government scientists and Moderna Inc, among the leading programmers, Reuters has heard. The national government is supporting Moderna’s vaccine job by almost half a billion dollars and it has chosen it as one of the earliest to get into large-scale human …
COVID-19 side effects outside lungs decoded Kumar Jeetendra | July 12, 2020 Scientists, for example those with Indian-origin, have given the first extensive breakdown of COVID-19’s effects beyond the lungs, also have advocated that physicians treat this like a multisystem disorder with indicators such as blood clots, kidney failure, and neurological disorders such as delirium. “I had been on the frontlines directly from the start. I discovered …
Russian experts Successfully Complete World’s First COVID-19 Vaccine trial Kumar Jeetendra | July 12, 2020 Sechenov University researchers have successfully completed clinical trials from the world’s very first COVID-19 vaccine on volunteers, chief researcher Elena Smolyarchuk told a Russian news socket Sunday, July 12. The Russian mission to India, at a tweet, quoted Smolyarchuk saying’the vaccine is’ safe’. Alexander Lukashev, Director of the Institute of Medical Parasitology Tropical and Vector-Borne …
